Consistent with its TGF-β antagonizing role, exogenous recombinant BMP-7 administration in vivo led to significant reduction of renal fibrosis in pre-clinical models of diabetic nephropathy and CKD (Wang, 2006). This evidence concerns the gene TGFB1 and renal fibrosis.